These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 15893586
1. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H. Brain Res Mol Brain Res; 2005 May 20; 136(1-2):45-53. PubMed ID: 15893586 [Abstract] [Full Text] [Related]
2. The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. Imbesi M, Arslan AD, Yildiz S, Sharma R, Gavin D, Tun N, Manev H, Uz T. J Pineal Res; 2009 Jan 20; 46(1):87-94. PubMed ID: 18798788 [Abstract] [Full Text] [Related]
3. Diurnal and circadian regulation of a melatonin receptor, MT1, in the golden rabbitfish, Siganus guttatus. Park YJ, Park JG, Hiyakawa N, Lee YD, Kim SJ, Takemura A. Gen Comp Endocrinol; 2007 Jan 15; 150(2):253-62. PubMed ID: 17046760 [Abstract] [Full Text] [Related]
4. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL. BMC Neurosci; 2004 Oct 28; 5():41. PubMed ID: 15511288 [Abstract] [Full Text] [Related]
5. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. Castro LM, Gallant M, Niles LP. J Neurochem; 2005 Dec 28; 95(5):1227-36. PubMed ID: 16313512 [Abstract] [Full Text] [Related]
6. Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells. McMillan CR, Sharma R, Ottenhof T, Niles LP. Neurosci Lett; 2007 Jun 04; 419(3):202-6. PubMed ID: 17482356 [Abstract] [Full Text] [Related]
7. Stimulation of melatonin receptors decreases calcium levels in xenopus tectal cells by activating GABA(C) receptors. Prada C, Udin SB, Wiechmann AF, Zhdanova IV. J Neurophysiol; 2005 Aug 04; 94(2):968-78. PubMed ID: 15817645 [Abstract] [Full Text] [Related]
8. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Lai L, Yuan L, Cheng Q, Dong C, Mao L, Hill SM. Breast Cancer Res Treat; 2009 Nov 04; 118(2):293-305. PubMed ID: 18979234 [Abstract] [Full Text] [Related]
9. Heterogeneous expression of melatonin receptor MT1 mRNA in the rat intestine under control and fasting conditions. Soták M, Mrnka L, Pácha J. J Pineal Res; 2006 Sep 04; 41(2):183-8. PubMed ID: 16879325 [Abstract] [Full Text] [Related]
10. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP. Eur J Pharmacol; 2007 Mar 29; 560(1):17-22. PubMed ID: 17303109 [Abstract] [Full Text] [Related]
11. Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling. Jilg A, Moek J, Weaver DR, Korf HW, Stehle JH, von Gall C. Eur J Neurosci; 2005 Dec 29; 22(11):2845-54. PubMed ID: 16324119 [Abstract] [Full Text] [Related]
12. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Sharma R, McMillan CR, Tenn CC, Niles LP. Brain Res; 2006 Jan 12; 1068(1):230-6. PubMed ID: 16375867 [Abstract] [Full Text] [Related]
13. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH. J Neurochem; 2006 May 12; 97(3):675-86. PubMed ID: 16573658 [Abstract] [Full Text] [Related]
14. Mammalian melatonin receptors: molecular biology and signal transduction. von Gall C, Stehle JH, Weaver DR. Cell Tissue Res; 2002 Jul 12; 309(1):151-62. PubMed ID: 12111545 [Abstract] [Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Borba JC, Henze IP, Silveira MS, Kubrusly RC, Gardino PF, de Mello MC, Hokoç JN, de Mello FG. Brain Res Dev Brain Res; 2005 May 12; 156(2):193-201. PubMed ID: 16099306 [Abstract] [Full Text] [Related]
16. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. Toma CD, Svoboda M, Arrich F, Ekmekcioglu C, Assadian O, Thalhammer T. J Pineal Res; 2007 Sep 12; 43(2):206-13. PubMed ID: 17645699 [Abstract] [Full Text] [Related]
17. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Wu YH, Zhou JN, Van Heerikhuize J, Jockers R, Swaab DF. Neurobiol Aging; 2007 Aug 12; 28(8):1239-47. PubMed ID: 16837102 [Abstract] [Full Text] [Related]
18. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation. Kokkola T, Vaittinen M, Laitinen JT. J Pineal Res; 2007 Oct 12; 43(3):255-62. PubMed ID: 17803522 [Abstract] [Full Text] [Related]
19. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Yu S, Zuo X, Li Y, Zhang C, Zhou M, Zhang YA, Uéda K, Chan P. Neurosci Lett; 2004 Aug 26; 367(1):34-9. PubMed ID: 15308292 [Abstract] [Full Text] [Related]
20. Melatonin receptor 1-dependent gene expression in the mouse pars tuberalis as revealed by cDNA microarray analysis and in situ hybridization. Unfried C, Burbach G, Korf HW, von Gall C. J Pineal Res; 2010 Mar 26; 48(2):148-56. PubMed ID: 20070488 [Abstract] [Full Text] [Related] Page: [Next] [New Search]